|
|
Volumn 8, Issue 1, 2009, Pages 10-
|
|
Regulatory watch: Non-inferiority-trial discussions impact new drug applications.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLYCOSIDE;
ANTIINFECTIVE AGENT;
GLYCOPEPTIDE;
ICLAPRIM;
ORITAVANCIN;
PYRIMIDINE DERIVATIVE;
TELAVANCIN;
DRUG APPROVAL;
DRUG SCREENING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEGAL ASPECT;
NOTE;
PHARMACOKINETICS;
UNITED STATES;
AMINOGLYCOSIDES;
ANTI-INFECTIVE AGENTS;
DRUG APPROVAL;
DRUG EVALUATION;
GLYCOPEPTIDES;
HUMANS;
PYRIMIDINES;
THERAPEUTIC EQUIVALENCY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 58849167392
PISSN: None
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2793 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|